Product
Supplier
Encyclopedia
Inquiry
Salcaprozate sodium SNAC buy - large image1
Salcaprozate sodium SNAC buy - image1

Salcaprozate sodium SNAC

GMP COA 28 Inquiries

Unit Price: Get Latest Price
CAS No.:

203787-91-1

Grade:

Pharmaceutical excipients

Content:

99.5%

Port:

北京市

Packaging:

25kg/Cardboard Drum

Price valid (until):

2026-01-24

Company Type:
Trader
Location:
China
Qualification:
Main Products:

Calcium L-5-Methyltetrahydrofolate,Glucosamine L-5-methyltetrahydrofolate,Vadadustat,Temozolomide,4-Amino-5-imidazole carboxamide hydrochloride,Salcaprozate sodium

  • Product Description

  • Seller Information

  • Inquiry History

  • Description


      Product Detail  


    White to pale yellow or slightly pink ish crystalline powder, 

    Soluble in anhydrous methanol, sparingly soluble anhydrous ethanol, insoluble in ethyl acetate

    Any impurity≤0.1%, Total impurities ≤0.5%

    Sodium content:  7.25%~8.01%

    Water content:  2.0%

    Items Specifications






    Certificates

    Basic Info
    Product Name:

    Salcaprozate Sodium

    Other Name:

    sodium,8-[(2-hydroxybenzoyl)amino]octanoate;Octanoic acid, 8-[(2-hydroxybenzoyl)amino]-, monosodium salt;SNAC,sodium 8-[(2-hydroxybenzoyl)amino]octanoate;Salcaprozate sodium;Octanoic acid, 8-[(2-hydroxybenzoyl)amino]-, sodium salt;2,5-Furandione,3-chlorodihydro-,(7R)-;N-[8-(2-Hydroxybenzoyl)amino]caprylic acid, disodium salt;Chlorotoluron Impurity 3

    CAS No.:

    203787-91-1

    Molecular Formula:

    C15H22NNaO4

    InChIKeys:

    OBKUJEVXEMKQMJ-UHFFFAOYSA-N

    Molecular Weight:

    303.33

    Exact Mass:

    301.12900240

    EC Number:

    231-019-4

    UNII:

    1YTW0422YU

    DSSTox ID:

    DTXSID50174306

    NCI Thesaurus Code:

    C75026

    Color/Form:

    White to Off-White

    Characteristics
    Melting Point:

    183 - 185°C

    Critical Temperature & Pressure:

    Inert atmosphere,Room Temperature

  • Seller Information
    Business Type:

    Trader

    Main Products:

    Calcium L-5-Methyltetrahydrofolate,Glucosamine L-5-methyltetrahydrofolate,Vadadustat,Temozolomide,4-Amino-5-imidazole carboxamide hydrochloride,Salcaprozate sodium

    Location:

    Room 101-602, 6th Floor, Building 15, No. 8 Yard, Liangshuihe 2nd Street, BDA, Beijing, China

    Payment Terms:

    L/C,100% TT in advance

    Total Annual Revenue:

    $1 million-$2.5 million

    Total Employees:

    11-50

    Year of Establishment:

    2017

    Beijing Ruqueen Biotech. Co., Ltd.  is a high-tech enterprise integrating the R&D and business promotion of novel food ingredients,  API s and intermediates, and novel pharmaceutical excipients. The company advocates a green, eco-friendly, and differentiated approach to health and wellness, emphasizing RSM ( Regulatory Starting Material )   research and QbD (Quality by Design) process development to ensure economical, environmentally friendly, safe, and quality-controllable manufacturing processes.

    The company operates a  1,000+ square meter R&D center  in the Beijing Economic-Technological Development Area (BDA), housing departments for process development, pilot-scale conversion, commercial production, quality research, and business promotion.

    The center's team comprises  Ph.D. and M.S. holders in chemistry  with over 20 years of commercial production experience in APIs. It is equipped with multiple advanced instruments including:   50/100L glass reactors , 20L rotary evaporators , HPLC , IR , LC-MS , GC-MS . Additionally ,  the company maintains  stable cooperative manufacturing bases  in Tianjin  City , Hebei  Province , Shandong  Province , Inner Mongolia Autonomous Region, and other regions, enabling scaled commercial production.

    The company conducts R&D and commercial manufacturing of:   Complex active pharmaceutical ingredients (APIs) , Pharmaceutical intermediates , Novel food ingredients  and Advanced pharmaceutical excipients

    The company provides comprehensive services including:
    ✓ Registration filing support for APIs/excipients (e.g., DMF/CEP preparation)
    ✓ Process optimization for existing pharmaceutical materials
    ✓ Enabling "API + Formulation" integration strategies for pharmaceutical partners

    Intellectual Property Achievements:
    ✓ 3 authorized invention patents
    ✓ 8 pending patent applications (including 2 PCT international filings)

  • Inquiry History
    28 Inquiries
    Country Product Purchase Quantity Date Posted
    India

    Salcaprozate Sodium

    1 KG Feb 13, 2026
    India

    Salcaprozate sodium

    1 KG May 8, 2024
    Tunisia

    Salcaprozate de sodium (SNAC)

    1 MT May 4, 2026
    India

    Salcaprozate Sodium

    1 KG Jul 20, 2026
    Italy

    Sodium Salcaprozate (SNAC)

    250 G Apr 17, 2026
    Pakistan

    SALCAPROZATE SODIUM SNAC

    450 KG Apr 10, 2026
    United States

    Salcaprozate Sodium

    500 KG Feb 18, 2026
    United States

    Salcaprozate Sodium/ SNAC 99%

    10 KG Feb 13, 2026
    Pakistan

    SALCAPROZATE SODIUM

    500 KG Feb 11, 2026
    South Africa

    Salcaprozate Sodium

    1 MT Oct 12, 2023
    Pakistan

    SALCAPROZATE SODIUM

    600 KG Jan 28, 2026
    United States

    Salcaprozate Sodium

    1 KG Nov 26, 2025
    Bangladesh

    Salcaprozate Sodium-GMP

    500 KG Nov 21, 2024
    United States

    Salcaprozate Sodium

    10 KG Sep 14, 2024
    Russia

    salcaprozate sodium

    20 KG Jan 18, 2024
    United Kingdom

    Salcaprozate Sodium -----the supporting excipient of Semaglutide

    5 KG Nov 17, 2023
    India

    Salcaprozate sodium

    1 KG Oct 7, 2023
    Pakistan

    SALCAPROZATE SODIUM

    180 KG Jul 20, 2026
    United Kingdom

    Salcaprozate Sodium

    1 MT Jul 17, 2026
    Pakistan

    SALCAPROZATE SODIUM

    50 KG Jun 5, 2026
    • 1
    • 2
    • Go to Page Go
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.